GAVISCON Side Effects

5850498-7 | Hepatic Enzyme Increased, Liver Disorder
on Aug 13, 2008 Female patient from UNITED STATES , 50 years of age, was diagnosed with gastrooesophageal reflux disease and was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: hepatic enzyme increased, liver disorder. Gaviscon dosage: Unk/unk/oral.

5730525-8 | Atrial Fibrillation, Palpitations
Patient was taking Gaviscon (View Usage). Patient had the following side effects: atrial fibrillation (What is atrial fibrillation?), palpitations on May 06, 2008 from UNITED STATES Additional patient health information: Male patient , 80 years of age, . Gaviscon dosage: . During the same period patient was treated with PANTOPRAZOLE SODIUM (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ), FLECAINIDE ACETATE (View Flecainide Acetate Review and Flecainide Acetate Label ).

5727686-3 | Dyspnoea, Hypersensitivity, Lip Swelling, Pharyngeal Oedema, Psoriasis, Urticaria
Adverse event was reported on Apr 23, 2008 by a Male patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) . Location: , 73 years of age, After Gaviscon was administered, patient had the following side effects: dyspnoea, hypersensitivity, lip swelling, pharyngeal oedema, psoriasis, urticaria. During the same period patient was treated with NARDIL /00037202/ (View Nardil /00037202/ Review and Nardil /00037202/ Label ), ALKA SELTZER /00057201/ (Dose: Unk) (View Alka-seltzer /00057201/ Review and Alka-seltzer /00057201/ Label ). Patient was hospitalized.

5573178-4 | Anaphylactic Reaction
on Dec 14, 2007 Female patient from CANADA , 16 years of age, was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: anaphylactic reaction. Gaviscon dosage: Dose: Unk.


5563086-7 | Anaphylactic Reaction
on Dec 14, 2007 Female patient from CANADA , 16 years of age, was treated with Gaviscon (View Usage). Patient had the following side effects: anaphylactic reaction. Gaviscon dosage: .

5562987-3 | Anaphylactic Reaction
Patient was taking Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: anaphylactic reaction on Dec 14, 2007 from CANADA Additional patient health information: Female patient , 16 years of age, . Gaviscon dosage: .

5526434-X | Angioedema
Adverse event was reported on Nov 16, 2007 by a Female patient taking Gaviscon (View Usage) (Dosage: ) . Location: , 45 years of age, weighting 266.8 lb, Patient experienced the following unwanted or unexpected effects: angioedema. During the same period patient was treated with LOSARTAN POTASSIUM (Dose: Unk) (View Losartan Potassium Review and Losartan Potassium Label ), TELFAST /01314201/ (Dose: Unk) (View Telfast /01314201/ Review and Telfast /01314201/ Label ), VESICARE /01735901/ (Dose: Unk) (View Vesicare /01735901/ Review and Vesicare /01735901/ Label ).

5519397-4 | Angioedema
on Nov 15, 2007 Female patient from UNITED KINGDOM , 45 years of age, weighting 121.3 lb, was treated with Gaviscon (View Usage). Patient had the following side effects: angioedema. Gaviscon dosage: . During the same period patient was treated with LOSARTAN POTASSIUM (View Losartan Potassium Review and Losartan Potassium Label ), TELFAST (View Telfast Review and Telfast Label ), VESICARE (View Vesicare Review and Vesicare Label ).

5514506-5 | Cardiospasm
on Nov 02, 2007 Female patient from UNITED KINGDOM , 62 years of age, weighting 158.7 lb, was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: cardiospasm. Gaviscon dosage: . During the same period patient was treated with CAPECITABINE (View Capecitabine Review and Capecitabine Label ), BEVACIZUMAB (View Bevacizumab Review and Bevacizumab Label ).

5464438-6 | Aphthous Stomatitis, Asthenia, C-reactive Protein Increased, Pyrexia, Weight Decreased
Patient was taking Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: aphthous stomatitis, asthenia, c-reactive protein increased, pyrexia, weight decreased on Sep 12, 2007 from FRANCE Additional patient health information: Male patient , 66 years of age, was diagnosed with gastrooesophageal reflux disease, prostatic adenoma, peripheral arterial occlusive disease and. Gaviscon dosage: Unk. During the same period patient was treated with OMIX (View Omix Review and Omix Label ), PLAVIX (View Plavix Review and Plavix Label ). Patient was hospitalized.

5294953-X | Blood Creatine Phosphokinase Increased, Electrocardiogram T Wave Inversion, Hypochloraemia, Hypokalaemia, Loss Of Consciousness, Metabolic Acidosis, Overdose, Pneumonia Aspiration
Adverse event was reported on Apr 02, 2007 by a Male patient taking Gaviscon (View Usage) (Dosage: 500ml See Dosage Text) . Location: UNITED KINGDOM , 35 years of age, Patient had the following side effects: blood creatine phosphokinase increased, electrocardiogram t wave inversion, hypochloraemia, hypokalaemia, loss of consciousness, metabolic acidosis, overdose, pneumonia aspiration. Patient was hospitalized.

5237324-4 | Pulmonary Embolism
on Feb 08, 2007 Male patient from , weighting 192.0 lb, was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: pulmonary embolism (What is pulmonary embolism?). Gaviscon dosage: . During the same period patient was treated with METOCLOPRAMIDE (10-20 Mg Tds, X3 Days Post Chemo.) (View Metoclopramide Review and Metoclopramide Label ), IMODIUM (View Imodium Review and Imodium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ONDANSETRON (8 Mg Post Chemo) (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (2 Mg Tds, X3 Days Post Chemo) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (View Slow-k Review and Slow-k Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5211548-4 | Pulmonary Embolism
on Jan 12, 2007 Male patient from , weighting 192.0 lb, was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: pulmonary embolism (What is pulmonary embolism?). Gaviscon dosage: . During the same period patient was treated with METOCLOPRAMIDE (10-20 Mg Tds, X3 Days Post Chemo.) (View Metoclopramide Review and Metoclopramide Label ), IMODIUM (View Imodium Review and Imodium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ONDANSETRON (8 Mg Post Chemo) (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (2 Mg Tds, X3 Days Post Chemo) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (View Slow-k Review and Slow-k Label ), PARACETAMOL (View Paracetamol Review and Paracetamol Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5199992-5 | Pulmonary Embolism
Patient was taking Gaviscon (View Usage). Patient had the following side effects: pulmonary embolism (What is pulmonary embolism?) on Jan 03, 2007 from Additional patient health information: Male patient , weighting 192.0 lb, . Gaviscon dosage: . During the same period patient was treated with METOCLOPRAMIDE (10-20 Mg Tds, X3 Days Post Chemo.) (View Metoclopramide Review and Metoclopramide Label ), IMODIUM (View Imodium Review and Imodium Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ), ONDANSETRON (8 Mg Post Chemo) (View Ondansetron Review and Ondansetron Label ), DEXAMETHASONE (2 Mg Tds, X3 Days Post Chemo) (View Dexamethasone Review and Dexamethasone Label ), SLOW K (View Slow-k Review and Slow-k Label ), ACETAMINOPHEN (View Acetaminophen Review and Acetaminophen Label ), ACYCLOVIR (View Acyclovir Review and Acyclovir Label ). Patient was hospitalized.

5160109-4 | Abdominal Pain Upper, Sepsis, Stomach Discomfort
Adverse event was reported on Aug 02, 2006 by a Female patient taking Gaviscon (View Usage) (Dosage: ) . Location: CANADA , 71 years of age, After Gaviscon was administered, patient had the following side effects: abdominal pain upper, sepsis (What is sepsis?), stomach discomfort. During the same period patient was treated with AGGRENOX (View Aggrenox Review and Aggrenox Label ), FLOVENT (View Flovent Review and Flovent Label ), APO FUROSEMIDE (View Apo-furosemide Review and Apo-furosemide Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LIPITOR (View Lipitor Review and Lipitor Label ), ALBUTEROL (View Albuterol Review and Albuterol Label ).

5153282-5 | Dysphagia
on Jan 25, 2005 Male patient from FRANCE , weighting 167.6 lb, was diagnosed with dysphagia, prophylaxis of nausea and vomiting, oesophageal carcinoma and was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: dysphagia. Gaviscon dosage: 3 Unit. During the same period patient was treated with EFFERALGAN (500 Mg) (View Efferalgan Review and Efferalgan Label ), ZOFRAN (8 Mg) (View Zofran Review and Zofran Label ), LEUCOVORIN CALCIUM (View Leucovorin Calcium Review and Leucovorin Calcium Label ), FLUOROURACIL (374 Mg Bolus And 1122 Mg Continuous Infusion, Q2w) (View Fluorouracil Review and Fluorouracil Label ), OXALIPLATIN (View Oxaliplatin Review and Oxaliplatin Label ). Patient was hospitalized.

5048258-2 | Global Amnesia, Lymphocyte Percentage Decreased, Neutrophil Percentage Increased, White Blood Cell Count Increased
on Jun 14, 2006 Male patient from , weighting 177.0 lb, was diagnosed with acute coronary syndrome and was treated with Gaviscon (View Usage). Patient had the following side effects: global amnesia, lymphocyte percentage decreased, neutrophil percentage increased, white blood cell count increased. Gaviscon dosage: . During the same period patient was treated with ALTACE (Unk) (View Altace Review and Altace Label ), TAMSULOSIN HCL (Unk) (View Tamsulosin Hcl Review and Tamsulosin Hcl Label ), ASPIRIN (Unk) (View Aspirin Review and Aspirin Label ), TOPROL XL (Unk) (View Toprol-xl Review and Toprol-xl Label ), CLOPIDOGREL (Unk) (View Clopidogrel Review and Clopidogrel Label ), FISH OIL (Unk) (View Fish Oil Review and Fish Oil Label ). Patient was hospitalized.

4814659-8 | Iron Deficiency Anaemia
Patient was taking Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: iron deficiency anaemia on Oct 19, 2005 from UNITED STATES Additional patient health information: Female patient , 60 years of age, . Gaviscon dosage: .

4773308-8 | Caesarean Section, Cervix Oedema, Failed Induction Of Labour
Adverse event was reported on Sep 05, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: 10 Mls) was diagnosed with dyspepsia, analgesic effect, antiemetic supportive care, induced labour and. Location: UNITED KINGDOM , 33 years of age, Patient experienced the following unwanted or unexpected effects: caesarean section, cervix oedema, failed induction of labour. During the same period patient was treated with KAPAKE (Unk, Unk) (View Kapake Review and Kapake Label ), PETHIDINE (100mg/day) (View Pethidine Review and Pethidine Label ), PROCHLORPERAZINE (12.5mg/day) (View Prochlorperazine Review and Prochlorperazine Label ), MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), SYNTOCINON (10 Iu In 500ml 0.9% Saline) (View Syntocinon Review and Syntocinon Label ). Patient was hospitalized.

4765758-0 | Caesarean Section, Failed Induction Of Labour
on Sep 05, 2005 Female patient from UNITED KINGDOM , 33 years of age, was diagnosed with dyspepsia, analgesic effect, antiemetic supportive care, induced labour and was treated with Gaviscon (View Usage). Patient had the following side effects: caesarean section, failed induction of labour. Gaviscon dosage: 10 Mls. During the same period patient was treated with KAPAKE (Unk, Unk) (View Kapake Review and Kapake Label ), PETHIDINE (100mg/day) (View Pethidine Review and Pethidine Label ), PROCHLORPERAZINE (12.5mg/day) (View Prochlorperazine Review and Prochlorperazine Label ), MISOPROSTOL (View Misoprostol Review and Misoprostol Label ), SYNTOCINON (10 Iu In 500ml 0.9% Saline) (View Syntocinon Review and Syntocinon Label ). Patient was hospitalized.

4736929-4 | Coagulopathy, Prothrombin Time Abnormal
on Jun 01, 2005 Female patient from , 79 years of age, was diagnosed with dyspepsia and was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: coagulopathy, prothrombin time abnormal. Gaviscon dosage: Dose: Unk. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ROLAIDS CALCIUM RICH (View Rolaids Calcium Rich Review and Rolaids Calcium Rich Label ), THYROXINE SODIUM (View Thyroxine Sodium Review and Thyroxine Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

4718372-7 | Bleeding Time Prolonged, Coagulopathy
Patient was taking Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: bleeding time prolonged, coagulopathy on May 17, 2005 from UNITED STATES Additional patient health information: Female patient , 79 years of age, was diagnosed with atrial fibrillation (What is atrial fibrillation?), hypothyroidism, blood pressure (What is blood pressure?), arthritis (What is arthritis?) and. Gaviscon dosage: 4tab Cumulative Dose. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), TUMS REGULAR TABLETS, PEPPERMINT (View Tums Regular Tablets, Peppermint Review and Tums Regular Tablets, Peppermint Label ), ROLAIDS (View Rolaids Review and Rolaids Label ), SYNTHROID (50mg Per Day) (View Synthroid Review and Synthroid Label ), DIOVAN (View Diovan Review and Diovan Label ), TOPROL XL (150mg Per Day) (View Toprol-xl Review and Toprol-xl Label ), DIGITEK (.25mg Per Day) (View Digitek Review and Digitek Label ), METHOTREXATE (2.5mg Three Times Per Week) (View Methotrexate Review and Methotrexate Label ).

4700722-9 | Coagulopathy, Prothrombin Time Abnormal
Adverse event was reported on Jun 01, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) was diagnosed with dyspepsia and. Location: , 79 years of age, Patient had the following side effects: coagulopathy, prothrombin time abnormal. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ROLAIDS CALCIUM RICH (View Rolaids Calcium Rich Review and Rolaids Calcium Rich Label ), THYROXINE SODIUM (View Thyroxine Sodium Review and Thyroxine Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

4695656-2 | Coagulopathy, Plasma Viscosity Decreased, Prothrombin Time Abnormal
on Jun 01, 2005 Female patient from , 79 years of age, was diagnosed with dyspepsia and was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: coagulopathy, plasma viscosity decreased, prothrombin time abnormal. Gaviscon dosage: Dose: Unk. During the same period patient was treated with WARFARIN SODIUM (View Warfarin Sodium Review and Warfarin Sodium Label ), CALCIUM CARBONATE (View Calcium Carbonate Review and Calcium Carbonate Label ), ROLAIDS CALCIUM RICH (View Rolaids Calcium Rich Review and Rolaids Calcium Rich Label ), THYROXINE SODIUM (View Thyroxine Sodium Review and Thyroxine Sodium Label ), VALSARTAN (View Valsartan Review and Valsartan Label ), METOPROLOL SUCCINATE (View Metoprolol Succinate Review and Metoprolol Succinate Label ), DIGOXIN (View Digoxin Review and Digoxin Label ), METHOTREXATE (View Methotrexate Review and Methotrexate Label ).

4686106-0 | Coagulopathy, Prothrombin Time Abnormal
on May 17, 2005 Female patient from , 79 years of age, was diagnosed with dyspepsia, hypothyroidism, blood pressure (What is blood pressure?), hypertension, cardiac disorder, arthritis (What is arthritis?) and was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: coagulopathy, prothrombin time abnormal. Gaviscon dosage: 4tab Cumulative Dose. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), TUMS REGULAR TABLETS, PEPPERMINT (View Tums Regular Tablets, Peppermint Review and Tums Regular Tablets, Peppermint Label ), ROLAIDS (View Rolaids Review and Rolaids Label ), SYNTHROID (50mg Per Day) (View Synthroid Review and Synthroid Label ), DIOVAN (View Diovan Review and Diovan Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DIGITEK (.25mg Per Day) (View Digitek Review and Digitek Label ), METHOTREXATE (2.5mg Three Times Per Week) (View Methotrexate Review and Methotrexate Label ).

4674613-6 | Blood Disorder, Coagulopathy, Prothrombin Time Abnormal
Patient was taking Gaviscon (View Usage). Patient had the following side effects: blood disorder, coagulopathy, prothrombin time abnormal on May 17, 2005 from Additional patient health information: Female patient , 79 years of age, was diagnosed with dyspepsia, hypothyroidism, blood pressure (What is blood pressure?), hypertension, cardiac disorder, arthritis (What is arthritis?) and. Gaviscon dosage: 4tab Cumulative Dose. During the same period patient was treated with COUMADIN (View Coumadin Review and Coumadin Label ), TUMS REGULAR TABLETS, PEPPERMINT (View Tums Regular Tablets, Peppermint Review and Tums Regular Tablets, Peppermint Label ), ROLAIDS (View Rolaids Review and Rolaids Label ), SYNTHROID (50mg Per Day) (View Synthroid Review and Synthroid Label ), DIOVAN (View Diovan Review and Diovan Label ), TOPROL XL (View Toprol-xl Review and Toprol-xl Label ), DIGITEK (.25mg Per Day) (View Digitek Review and Digitek Label ), METHOTREXATE (2.5mg Three Times Per Week) (View Methotrexate Review and Methotrexate Label ).

4673245-3 | Electrocardiogram Abnormal
Adverse event was reported on May 17, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) was diagnosed with dyspepsia and. Location: , 78 years of age, After Gaviscon was administered, patient had the following side effects: electrocardiogram abnormal. Patient was hospitalized.

4664491-3 | Chest Pain, Coronary Artery Occlusion, Coronary Artery Stenosis
on May 10, 2005 Female patient from , 55 years of age, was diagnosed with dyspepsia and was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: chest pain (What is chest pain?), coronary artery occlusion, coronary artery stenosis. Gaviscon dosage: Dose: Unk. During the same period patient was treated with DIURETICS (Dose: Unk) (View Diuretics Review and Diuretics Label ), ATORVASTATIN CALCIUM (Dose: Unk) (View Atorvastatin Calcium Review and Atorvastatin Calcium Label ), GARLIC (Dose: Unk) (View Garlic Review and Garlic Label ), MULTIVITAMINS, PLAIN (Dose: Unk) (View Multivitamins, Plain Review and Multivitamins, Plain Label ). Patient was hospitalized and became disabled.

4661532-4 | Electrocardiogram Abnormal
on May 01, 2005 Female patient from , 78 years of age, was treated with Gaviscon (View Usage). Patient had the following side effects: electrocardiogram abnormal. Gaviscon dosage: . Patient was hospitalized.

4658820-4 | Chest Pain, Coronary Artery Stenosis
Patient was taking Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: chest pain (What is chest pain?), coronary artery stenosis on Apr 29, 2005 from Additional patient health information: Female patient , 56 years of age, weighting 213.4 lb, was diagnosed with blood cholesterol increased and. Gaviscon dosage: . During the same period patient was treated with HIGH BLOOD PRESSURE PILL (View High Blood Pressure Pill Review and High Blood Pressure Pill Label ), WATER PILL (View Water Pill Review and Water Pill Label ), LIPITOR (View Lipitor Review and Lipitor Label ), GARLIC WITH MULTIVITAMINS (View Garlic With Multivitamins Review and Garlic With Multivitamins Label ). Patient was hospitalized.

4648598-2 | Confusional State, Convulsion, Disorientation, Feeling Abnormal, Respiratory Arrest, Sleep Disorder
Adverse event was reported on Apr 20, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) was diagnosed with gastrooesophageal reflux disease and. Location: , 59 years of age, weighting 136.7 lb, Patient experienced the following unwanted or unexpected effects: confusional state, convulsion, disorientation, feeling abnormal, respiratory arrest, sleep disorder (What is sleep disorder?). During the same period patient was treated with LITHIUM CARBONATE (Dose: Unk) (View Lithium Carbonate Review and Lithium Carbonate Label ), PANTOPRAZOLE SODIUM (Dose: Unk) (View Pantoprazole Sodium Review and Pantoprazole Sodium Label ).

4640379-9 | Confusional State, Convulsion, Disorientation, Feeling Abnormal, Respiratory Arrest, Sleep Disorder
on Apr 13, 2005 Female patient from , 59 years of age, weighting 136.7 lb, was diagnosed with gastrooesophageal reflux disease, bipolar disorder (What is bipolar disorder?) and was treated with Gaviscon (View Usage). Patient had the following side effects: confusional state, convulsion, disorientation, feeling abnormal, respiratory arrest, sleep disorder (What is sleep disorder?). Gaviscon dosage: . During the same period patient was treated with LITHIUM (View Lithium Review and Lithium Label ), PROTONIX (View Protonix Review and Protonix Label ).

4622473-1 | Condition Aggravated, Dysgeusia, Gastrooesophageal Reflux Disease, Impaired Gastric Emptying, Post Procedural Complication, Urinary Retention
on Mar 22, 2005 Female patient from , 37 years of age, was diagnosed with dyspepsia and was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: condition aggravated, dysgeusia, gastrooesophageal reflux disease, impaired gastric emptying, post procedural complication, urinary retention. Gaviscon dosage: Dose: As Required. During the same period patient was treated with TAGAMET (Dose: As Required) (View Tagamet Review and Tagamet Label ), RANITIDINE HYDROCHLORIDE (Dose: Unk) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), METOCLOPRAMIDE (Dose: Unk) (View Metoclopramide Review and Metoclopramide Label ), SUMATRIPTAN (Dose: Unk) (View Sumatriptan Review and Sumatriptan Label ), OXYCODONE HCL (Dose: Unk) (View Oxycodone Hcl Review and Oxycodone Hcl Label ), NABUMETONE (Dose: Unk) (View Nabumetone Review and Nabumetone Label ), CARBAMAZEPINE (Dose: Unk) (View Carbamazepine Review and Carbamazepine Label ), FLUOXETINE HCL (Dose: Unk) (View Fluoxetine Hcl Review and Fluoxetine Hcl Label ). Patient was hospitalized.

4609834-1 | Diarrhoea, Diverticulum, Haemorrhoidal Haemorrhage, Rectal Haemorrhage
Patient was taking Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: diarrhoea, diverticulum, haemorrhoidal haemorrhage, rectal haemorrhage on Mar 08, 2005 from Additional patient health information: Male patient , 70 years of age, was diagnosed with hiatus hernia and. Gaviscon dosage: Dose: Unk. During the same period patient was treated with RANITIDINE HYDROCHLORIDE (Dose: Unk) (View Ranitidine Hydrochloride Review and Ranitidine Hydrochloride Label ), METFORMIN HCL (Dose: Unk) (View Metformin Hcl Review and Metformin Hcl Label ). Patient was hospitalized.

4601430-5 | Diarrhoea, Diverticulum, Haemorrhoids, Rectal Haemorrhage
Adverse event was reported on Feb 22, 2005 by a Male patient taking Gaviscon (View Usage) (Dosage: ) was diagnosed with hiatus hernia and. Location: , 70 years of age, Patient had the following side effects: diarrhoea, diverticulum, haemorrhoids, rectal haemorrhage. During the same period patient was treated with ZANTAC (View Zantac Review and Zantac Label ), GLUCOPHAGE (View Glucophage Review and Glucophage Label ). Patient was hospitalized.

4597444-4 | Breast Cancer
on Feb 23, 2005 Female patient from , 76 years of age, weighting 114.6 lb, was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: breast cancer (What is breast cancer?). Gaviscon dosage: . During the same period patient was treated with HYDROCHLOROTHIAZIDE (View Hydrochlorothiazide Review and Hydrochlorothiazide Label ), LISINOPRIL (View Lisinopril Review and Lisinopril Label ), ASPIRIN (View Aspirin Review and Aspirin Label ), ZOCOR (View Zocor Review and Zocor Label ).

4585359-7 | Diabetes Mellitus Non-insulin-dependent
on Feb 09, 2005 Female patient from , 82 years of age, weighting 138.9 lb, was diagnosed with abdominal pain upper and was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: diabetes mellitus non-insulin-dependent. Gaviscon dosage: . During the same period patient was treated with POTASSIUM CHLORIDE (Dose: Unk) (View Potassium Chloride Review and Potassium Chloride Label ), RABEPRAZOLE SODIUM (View Rabeprazole Sodium Review and Rabeprazole Sodium Label ), AMLODIPINE (View Amlodipine Review and Amlodipine Label ), SIMVASTATIN (View Simvastatin Review and Simvastatin Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), SOTALOL HYDROCHLORIDE (Dose: Unk) (View Sotalol Hydrochloride Review and Sotalol Hydrochloride Label ), THYROXINE SODIUM (View Thyroxine Sodium Review and Thyroxine Sodium Label ), FRUSEMIDE (View Frusemide Review and Frusemide Label ).

4575751-9 | Diabetes Mellitus
Patient was taking Gaviscon (View Usage). Patient had the following side effects: diabetes mellitus on Jan 31, 2005 from Additional patient health information: Female patient , 82 years of age, weighting 138.9 lb, was diagnosed with hypertension, hypothyroidism and. Gaviscon dosage: . During the same period patient was treated with K DUR 10 (View K-dur 10 Review and K-dur 10 Label ), ACIPHEX (View Aciphex Review and Aciphex Label ), NORVASC (View Norvasc Review and Norvasc Label ), ZOCOR (View Zocor Review and Zocor Label ), GEMFIBROZIL (View Gemfibrozil Review and Gemfibrozil Label ), BETAPACE (View Betapace Review and Betapace Label ), SYNTHROID (View Synthroid Review and Synthroid Label ), LASIX (View Lasix Review and Lasix Label ).

4569020-0 | Condition Aggravated, Gallbladder Disorder
Adverse event was reported on Jan 27, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) was diagnosed with dyspepsia and. Location: , 69 years of age, weighting 192.9 lb, After Gaviscon was administered, patient had the following side effects: condition aggravated, gallbladder disorder. Patient was hospitalized and became disabled.

4562697-5 | Gallbladder Disorder
on Jan 19, 2005 Female patient from , 69 years of age, weighting 194.0 lb, was treated with Gaviscon (View Usage). Patient experienced the following unwanted or unexpected effects: gallbladder disorder. Gaviscon dosage: . Patient was hospitalized.

4562365-X | Abasia, Back Pain, Blood Glucose Fluctuation, Blood Glucose Increased, Fall, Intervertebral Disc Protrusion, Spinal Fracture, Thrombosis, Walking Aid User
on Jan 18, 2005 Female patient from , 53 years of age, weighting 159.0 lb, was diagnosed with gastrooesophageal reflux disease and was treated with Gaviscon (View Usage). Patient had the following side effects: abasia, back pain (What is back pain?), blood glucose fluctuation, blood glucose increased, fall (What is fall?), intervertebral disc protrusion, spinal fracture, thrombosis, walking aid user. Gaviscon dosage: Dose: Unk. During the same period patient was treated with HUMULIN N (Dose: Unk) (View Humulin N Review and Humulin N Label ), PHENYTOIN (Dose: Unk) (View Phenytoin Review and Phenytoin Label ), GABAPENTIN (Dose: Unk) (View Gabapentin Review and Gabapentin Label ), VALSARTAN (Dose: Unk) (View Valsartan Review and Valsartan Label ), EZETIMIBE (Dose: Unk) (View Ezetimibe Review and Ezetimibe Label ), METOCLOPRAMIDE (Dose: Unk) (View Metoclopramide Review and Metoclopramide Label ), LANTUS (Dose: Unk) (View Lantus Review and Lantus Label ). Patient was hospitalized and became disabled.

4560442-0 | Blood Glucose Increased, Diabetes Mellitus, Fatigue, Lung Infection, Rash, Somnolence, Weight Increased
Patient was taking Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: blood glucose increased, diabetes mellitus, fatigue, lung infection, rash (What is rash?), somnolence, weight increased on Dec 07, 2004 from Additional patient health information: Female patient , 38 years of age, weighting 154.3 lb, was diagnosed with gastrooesophageal reflux disease, seasonal allergy, contraception and. Gaviscon dosage: . During the same period patient was treated with ALLEGRA (View Allegra Review and Allegra Label ), NASONEX (View Nasonex Review and Nasonex Label ), DEPO PROVERA (View Depo-provera Review and Depo-provera Label ).

4555757-6 | Blood Glucose Increased, Diabetes Mellitus, Diabetes Mellitus Non-insulin-dependent, Fatigue, Lung Infection, Rash, Somnolence, Weight Increased
Adverse event was reported on Jan 11, 2005 by a Female patient taking Gaviscon (View Usage) (Dosage: Dose: Unk) was diagnosed with gastrooesophageal reflux disease and. Location: , 38 years of age, weighting 154.0 lb, Patient experienced the following unwanted or unexpected effects: blood glucose increased, diabetes mellitus, diabetes mellitus non-insulin-dependent, fatigue, lung infection, rash (What is rash?), somnolence, weight increased. During the same period patient was treated with FEXOFENADINE HYDROCHLORIDE (Dose: Unk) (View Fexofenadine Hydrochloride Review and Fexofenadine Hydrochloride Label ), MOMETASONE FUROATE (Dose: Unk) (View Mometasone Furoate Review and Mometasone Furoate Label ), MEDROXYPROGESTERONE ACETATE (Dose: Unk) (View Medroxyprogesterone Acetate Review and Medroxyprogesterone Acetate Label ).

4550202-9 | Abasia, Back Pain, Blood Glucose Fluctuation, Blood Glucose Increased, Fall, Intervertebral Disc Protrusion, Spinal Fracture, Thrombosis, Walking Aid User
on Jan 03, 2005 Female patient from , 53 years of age, weighting 160.3 lb, was diagnosed with gastrooesophageal reflux disease, diabetes mellitus, epilepsy (What is epilepsy?), hypertension, blood cholesterol increased and was treated with Gaviscon (View Usage). Patient had the following side effects: abasia, back pain (What is back pain?), blood glucose fluctuation, blood glucose increased, fall (What is fall?), intervertebral disc protrusion, spinal fracture, thrombosis, walking aid user. Gaviscon dosage: . During the same period patient was treated with LANTUS (View Lantus Review and Lantus Label ), HUMULIN N (View Humulin N Review and Humulin N Label ), DILANTIN (View Dilantin Review and Dilantin Label ), NEURONTIN (View Neurontin Review and Neurontin Label ), DIOVAN (View Diovan Review and Diovan Label ), ZETIA (View Zetia Review and Zetia Label ), METOCLOPRAMIDE (View Metoclopramide Review and Metoclopramide Label ). Patient was hospitalized and became disabled.

4543217-8 | Barrett's Oesophagus, Gastrooesophageal Reflux Disease, Nephrolithiasis
on Dec 23, 2004 Male patient from , 49 years of age, was diagnosed with dyspepsia and was treated with Gaviscon (View Usage). After Gaviscon was administered, patient had the following side effects: barrett's oesophagus, gastrooesophageal reflux disease, nephrolithiasis. Gaviscon dosage: Dose: Unk. During the same period patient was treated with CALCIUM CARBONATE (Dose: Unk) (View Calcium Carbonate Review and Calcium Carbonate Label ), ROLAIDS CALCIUM RICH (View Rolaids Calcium Rich Review and Rolaids Calcium Rich Label ), FAMOTIDINE (View Famotidine Review and Famotidine Label ).